Irlic 10 Tablet contains Dydrogesterone 10 mg, a synthetic hormone structurally similar to natural progesterone. It is primarily indicated for the management of various gynecological disorders related to progesterone deficiency, including menstrual irregularities, secondary amenorrhea, and abnormal uterine bleeding. Additionally, Irlic 10 is used in hormone replacement therapy to support luteal phase insufficiency and to prevent threatened or habitual miscarriage in early pregnancy. The pharmacological action of Dydrogesterone involves binding to progesterone receptors, thereby regulating the endometrial lining and maintaining pregnancy. It is well-absorbed orally, with a favorable safety profile and minimal androgenic or estrogenic effects. The recommended dosage varies according to the indication and patient response, and it should be administered under medical supervision. Common side effects are generally mild and may include nausea, headache, and breast tenderness. Irlic 10 Tablet is contraindicated in patients with known hypersensitivity to dydrogesterone or any component of the formulation, active thrombophlebitis, or undiagnosed vaginal bleeding. Caution is advised in patients with liver dysfunction or a history of thromboembolic disorders. Regular monitoring and adherence to prescribed dosage ensure optimal therapeutic outcomes with minimal adverse effects.